Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives.
暂无分享,去创建一个
S. Blankenberg | S. Heymans | C. Weber | U. Landmesser | S. Dimmeler | T. Zeller | J. Haas | B. Meder | R. Hajjar | D. Leistner | S. Nakagawa | T. Thum | S. Engelhardt | M. Karakas | W. Poller | P. Jakob
[1] A. Bayés‐Genís,et al. Transitioning from usual care to biomarker-based personalized and precision medicine in heart failure: call for action. , 2018, European heart journal.
[2] Yajnavalka Banerjee,et al. A Highly Durable RNAi Therapeutic Inhibitor of PCSK9. , 2017, The New England journal of medicine.
[3] Stanley T Crooke,et al. Cellular uptake and trafficking of antisense oligonucleotides , 2017, Nature Biotechnology.
[4] anastasia. khvorova,et al. The chemical evolution of oligonucleotide therapies of clinical utility , 2017, Nature Biotechnology.
[5] J. Rossi,et al. Aptamers as targeted therapeutics: current potential and challenges , 2016, Nature Reviews Drug Discovery.
[6] Saumya Das,et al. High Throughput Sequencing of Extracellular RNA from Human Plasma , 2017, PloS one.
[7] A. Khvorova. Oligonucleotide Therapeutics - A New Class of Cholesterol-Lowering Drugs. , 2017, The New England journal of medicine.
[8] L. Räber,et al. Profiling and validation of circulating microRNAs for cardiovascular events in patients presenting with ST-segment elevation myocardial infarction , 2016, European heart journal.
[9] C. Weber,et al. Small but smart: MicroRNAs orchestrate atherosclerosis development and progression. , 2016, Biochimica et Biophysica Acta.
[10] U. Eriksson,et al. The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy. , 2016, Journal of the American College of Cardiology.
[11] Alfonso Valencia,et al. The BLUEPRINT Data Analysis Portal. , 2016, Cell systems.
[12] Pierre-Étienne Jacques,et al. The International Human Epigenome Consortium Data Portal. , 2016, Cell systems.
[13] Steven J. M. Jones,et al. The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery , 2016, Cell.
[14] Matthew T. Maurano,et al. Genetic Drivers of Epigenetic and Transcriptional Variation in Human Immune Cells , 2016, Cell.
[15] T. Thum,et al. Long Noncoding RNAs in Cardiovascular Pathology, Diagnosis, and Therapy. , 2016, Circulation.
[16] F. Edfors,et al. Gene‐specific correlation of RNA and protein levels in human cells and tissues , 2016, Molecular systems biology.
[17] K. Rayner,et al. Nanomedicine Meets microRNA: Current Advances in RNA-Based Nanotherapies for Atherosclerosis. , 2016, Arteriosclerosis, thrombosis, and vascular biology.
[18] U. Landmesser,et al. Circulating exosomal microRNAs predict functional recovery after MitraClip repair of severe mitral regurgitation. , 2016, International journal of cardiology.
[19] Volkmar Falk,et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.
[20] A. Laucevičius,et al. Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review , 2016, Cardiovascular research.
[21] Garret A. FitzGerald,et al. Measure for Measure: Biomarker standards and transparency , 2016, Science Translational Medicine.
[22] J. Mendell. Targeting a Long Noncoding RNA in Breast Cancer. , 2016, The New England journal of medicine.
[23] S. Fichtlscherer,et al. Transcoronary gradients of vascular miRNAs and coronary atherosclerotic plaque characteristics. , 2016, European heart journal.
[24] J. Hulot,et al. Gene therapy for the treatment of heart failure: promise postponed. , 2016, European heart journal.
[25] Daniel G. Anderson,et al. RNAi targeting multiple cell adhesion molecules reduces immune cell recruitment and vascular inflammation after myocardial infarction , 2016, Science Translational Medicine.
[26] T. Thum,et al. Long noncoding RNAs in kidney and cardiovascular diseases , 2016, Nature Reviews Nephrology.
[27] Gary H Lyman,et al. Biomarker Tests for Molecularly Targeted Therapies--The Key to Unlocking Precision Medicine. , 2016, The New England journal of medicine.
[28] Sreekala S. Nampoothiri,et al. ISCHEMIRs: Finding a Way Through the Obstructed Cerebral Arteries. , 2016, Current drug targets.
[29] S. Engelhardt,et al. Essential Role for Premature Senescence of Myofibroblasts in Myocardial Fibrosis. , 2016, Journal of the American College of Cardiology.
[30] P. Quax,et al. The multifactorial nature of microRNAs in vascular remodelling. , 2016, Cardiovascular research.
[31] Jian Wang,et al. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy. , 2016, Cardiovascular research.
[32] P. Fasanaro,et al. Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing , 2016, Scientific Reports.
[33] D. Marsh,et al. Comparison of Methodologies to Detect Low Levels of Hemolysis in Serum for Accurate Assessment of Serum microRNAs , 2016, PloS one.
[34] Fen Hu,et al. Inhibition of microRNA-155 ameliorates experimental autoimmune myocarditis by modulating Th17/Treg immune response , 2016, Journal of Molecular Medicine.
[35] Frank Rühle,et al. Long non-coding RNA Databases in Cardiovascular Research , 2016, Genom. Proteom. Bioinform..
[36] B. Schroen,et al. Long noncoding RNA MALAT1-derived mascRNA is involved in cardiovascular innate immunity. , 2016, Journal of molecular cell biology.
[37] W. Paulus,et al. Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction. , 2016, JACC. Heart failure.
[38] K. Rayner,et al. Long Noncoding RNAs in the Heart: The Regulatory Roadmap of Cardiovascular Development and Disease. , 2016, Circulation. Cardiovascular genetics.
[39] Stefanie Dimmeler,et al. Long Noncoding RNAs: From Clinical Genetics to Therapeutic Targets? , 2016, Journal of the American College of Cardiology.
[40] Yingying Zhang,et al. Silencing MicroRNA-155 Attenuates Cardiac Injury and Dysfunction in Viral Myocarditis via Promotion of M2 Phenotype Polarization of Macrophages , 2016, Scientific Reports.
[41] A. Yu,et al. Bioengineering of noncoding RNAs for research agents and therapeutics , 2016, Wiley interdisciplinary reviews. RNA.
[42] B. Schroen,et al. Long Non-Coding RNA Malat-1 Is Dispensable during Pressure Overload-Induced Cardiac Remodeling and Failure in Mice , 2016, PloS one.
[43] A. Schambach,et al. Long noncoding RNA Chast promotes cardiac remodeling , 2016, Science Translational Medicine.
[44] Junyi Yu,et al. Circulating 'lncRNA OTTHUMT00000387022' from monocytes as a novel biomarker for coronary artery disease. , 2016, Cardiovascular research.
[45] S. Crooke,et al. RNA cleavage products generated by antisense oligonucleotides and siRNAs are processed by the RNA surveillance machinery , 2016, Nucleic acids research.
[46] P. Jose,et al. Circulating “LncPPARδ” From Monocytes as a Novel Biomarker for Coronary Artery Diseases , 2016, Medicine.
[47] C. Caldas,et al. Double-stranded microRNA mimics can induce length- and passenger strand–dependent effects in a cell type–specific manner , 2016, RNA.
[48] S. Freier,et al. Natural antisense RNA promotes 3′ end processing and maturation of MALAT1 lncRNA , 2016, Nucleic acids research.
[49] Finding function in mystery transcripts , 2016, Nature.
[50] E. Creemers,et al. Function and Therapeutic Potential of Noncoding RNAs in Cardiac Fibrosis. , 2016, Circulation research.
[51] Y. Suárez,et al. VEGF-Induced Expression of miR-17–92 Cluster in Endothelial Cells Is Mediated by ERK/ELK1 Activation and Regulates Angiogenesis , 2016, Circulation research.
[52] M. Behlke,et al. Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides , 2015, Nucleic acids research.
[53] B. Gloss,et al. The specificity of long noncoding RNA expression. , 2016, Biochimica et biophysica acta.
[54] Daniel G. Anderson,et al. Myocardial Delivery of Lipidoid Nanoparticle Carrying modRNA Induces Rapid and Transient Expression. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.
[55] K. Sanbonmatsu. Towards structural classification of long non-coding RNAs. , 2016, Biochimica et biophysica acta.
[56] S. Nakagawa. Lessons from reverse-genetic studies of lncRNAs. , 2016, Biochimica et biophysica acta.
[57] Piero Carninci,et al. Discovery and functional analysis of lncRNAs: Methodologies to investigate an uncharacterized transcriptome. , 2016, Biochimica et biophysica acta.
[58] J. Wilusz. Long noncoding RNAs: Re-writing dogmas of RNA processing and stability. , 2016, Biochimica et biophysica acta.
[59] O. Merkel,et al. Tackling breast cancer chemoresistance with nano-formulated siRNA , 2016, Gene Therapy.
[60] A. Hoes,et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. , 2016, Revista espanola de cardiologia.
[61] Charles S Bond,et al. The ins and outs of lncRNA structure: How, why and what comes next? , 2016, Biochimica et biophysica acta.
[62] S. Nakagawa,et al. Clues to long noncoding RNA taxonomy. , 2016, Biochimica et biophysica acta.
[63] L. D. de Windt,et al. Antisense MicroRNA Therapeutics in Cardiovascular Disease: Quo Vadis? , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.
[64] R. Guigó,et al. CARMEN, a human super enhancer-associated long noncoding RNA controlling cardiac specification, differentiation and homeostasis. , 2015, Journal of molecular and cellular cardiology.
[65] A. Schober,et al. MicroRNA-specific regulatory mechanisms in atherosclerosis. , 2015, Journal of molecular and cellular cardiology.
[66] Thomas Thum,et al. Development of Long Noncoding RNA-Based Strategies to Modulate Tissue Vascularization , 2015, Journal of the American College of Cardiology.
[67] R. de Cabo,et al. Identification of miR-148a as a novel regulator of cholesterol metabolism , 2015, Nature Medicine.
[68] Klaus Pantel,et al. Data Normalization Strategies for MicroRNA Quantification. , 2015, Clinical chemistry.
[69] R. Krauss,et al. Proprotein convertase subtilisin/kexin type 9 inhibition: a new therapeutic mechanism for reducing cardiovascular disease risk. , 2015, Circulation.
[70] A. Zeiher,et al. Identification and Characterization of Hypoxia-Regulated Endothelial Circular RNA. , 2015, Circulation research.
[71] Nikolaus Rajewsky,et al. Identification and Characterization of Circular RNAs As a New Class of Putative Biomarkers in Human Blood , 2015, PloS one.
[72] E. Stroes,et al. A sense of excitement for a specific Lp(a)-lowering therapy , 2015, The Lancet.
[73] J. Witztum,et al. Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study , 2015, The Lancet.
[74] P. Jose,et al. Plasma long non-coding RNA, CoroMarker, a novel biomarker for diagnosis of coronary artery disease. , 2015, Clinical science.
[75] R. Hegele,et al. Trial Watch: Antisenses working overtime in lipids , 2015, Nature Reviews Endocrinology.
[76] Z. Szallasi,et al. CAUSEL: An epigenome and genome editing pipeline for establishing function of non-coding GWAS variants , 2015, Nature Medicine.
[77] Yu Zhang,et al. siRNA Versus miRNA as Therapeutics for Gene Silencing , 2015, Molecular therapy. Nucleic acids.
[78] J. Lieberman,et al. Knocking down disease: a progress report on siRNA therapeutics , 2015, Nature Reviews Genetics.
[79] R. Tekade,et al. Nanocarriers Assisted siRNA Gene Therapy for the Management of Cardiovascular Disorders. , 2015, Current pharmaceutical design.
[80] Sabine C. Mueller,et al. Influence of next-generation sequencing and storage conditions on miRNA patterns generated from PAXgene blood. , 2015, Analytical chemistry.
[81] 中山 幸輝. A long noncoding RNA protects the heart from pathological hypertrophy , 2015 .
[82] Trees-Juen Chuang,et al. Biogenesis, identification, and function of exonic circular RNAs , 2015, Wiley interdisciplinary reviews. RNA.
[83] Judy Lieberman,et al. Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown , 2015, Nature Biotechnology.
[84] S. Verjovski-Almeida,et al. Global analysis of biogenesis, stability and sub-cellular localization of lncRNAs mapping to intragenic regions of the human genome , 2015, RNA biology.
[85] Jiang-xia Zhao,et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis , 2015, Cell Research.
[86] M. Halushka,et al. Extracellular vesicle microRNA transfer in cardiovascular disease. , 2015, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[87] B. Schroen,et al. Long noncoding RNAs in cardiac development and ageing , 2015, Nature Reviews Cardiology.
[88] Charles P. Lin,et al. Silencing of CCR2 in myocarditis. , 2015, European heart journal.
[89] Q. Ning,et al. Losartan reverses the down-expression of long noncoding RNA-NR024118 and Cdkn1c induced by angiotensin II in adult rat cardiac fibroblasts. , 2015, Pathologie-biologie.
[90] C. Newton-Cheh,et al. Genome-wide association studies of late-onset cardiovascular disease. , 2015, Journal of molecular and cellular cardiology.
[91] A. Schober,et al. MicroRNA-mediated mechanisms of the cellular stress response in atherosclerosis , 2015, Nature Reviews Cardiology.
[92] A. Schober,et al. Chemokines and microRNAs in atherosclerosis , 2015, Cellular and Molecular Life Sciences.
[93] Alexander J. Federation,et al. RNA Exosome-Regulated Long Non-Coding RNA Transcription Controls Super-Enhancer Activity , 2015, Cell.
[94] M. Dirin,et al. Going beyond the liver: progress and challenges of targeted delivery of siRNA therapeutics. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[95] Igor Ulitsky,et al. Methods for distinguishing between protein-coding and long noncoding RNAs and the elusive biological purpose of translation of long noncoding RNAs , 2015, bioRxiv.
[96] N. Snead,et al. Lipid nanoparticle siRNA treatment of Ebola virus Makona infected nonhuman primates , 2015, Nature.
[97] P. Talmud,et al. Identifying functional noncoding variants from genome-wide association studies for cardiovascular disease and related traits , 2015, Current opinion in lipidology.
[98] S. Zeng,et al. A general approach to high-yield biosynthesis of chimeric RNAs bearing various types of functional small RNAs for broad applications , 2015, Nucleic acids research.
[99] Joel T. Dudley,et al. Genome-wide significant loci: how important are they? Systems genetics to understand heritability of coronary artery disease and other common complex disorders. , 2015, Journal of the American College of Cardiology.
[100] S. Dimmeler,et al. MicroRNAs in myocardial infarction , 2015, Nature Reviews Cardiology.
[101] M. Leach,et al. Scientific and Regulatory Policy Committee Points-to-consider Paper* , 2015, Toxicologic pathology.
[102] G. Condorelli,et al. Long noncoding RNAs and microRNAs in cardiovascular pathophysiology. , 2015, Circulation research.
[103] S. Dimmeler,et al. Long Noncoding RNAs in Cardiovascular Diseases , 2015, Circulation Research.
[104] Y. Devaux,et al. Diagnostic and prognostic value of circulating microRNAs in patients with acute chest pain , 2015, Journal of internal medicine.
[105] J. Rinn,et al. Localization and abundance analysis of human lncRNAs at single-cell and single-molecule resolution , 2015, Genome Biology.
[106] B. Suess,et al. A Universal Aptamer Chimera for the Delivery of Functional microRNA-126. , 2015, Nucleic acid therapeutics.
[107] Christine S. Siegismund,et al. Differential Cardiac MicroRNA Expression Predicts the Clinical Course in Human Enterovirus Cardiomyopathy , 2015, Circulation. Heart failure.
[108] R. Guigó,et al. Genome-wide profiling of the cardiac transcriptome after myocardial infarction identifies novel heart-specific long non-coding RNAs , 2014, European heart journal.
[109] Joachim Thiery,et al. Comparison of Whole Blood RNA Preservation Tubes and Novel Generation RNA Extraction Kits for Analysis of mRNA and MiRNA Profiles , 2014, PloS one.
[110] Amy Chan,et al. Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing. , 2014, Journal of the American Chemical Society.
[111] C. Ramírez,et al. Relevance of microRNA in metabolic diseases , 2014, Critical reviews in clinical laboratory sciences.
[112] Thomas Thum,et al. Noncoding RNAs and myocardial fibrosis , 2014, Nature Reviews Cardiology.
[113] Guocheng Yuan,et al. LincRNA-p21 Regulates Neointima Formation, Vascular Smooth Muscle Cell Proliferation, Apoptosis, and Atherosclerosis by Enhancing p53 Activity , 2014, Circulation.
[114] Q. Jiang,et al. Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus , 2014, Cell Death and Disease.
[115] H. Jo,et al. Role of flow-sensitive microRNAs in endothelial dysfunction and atherosclerosis: mechanosensitive athero-miRs. , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[116] E. Westhof,et al. Biogenesis of Circular RNAs , 2014, Cell.
[117] Y. Devaux,et al. Long Noncoding RNAs in Patients With Acute Myocardial Infarction , 2014, Circulation research.
[118] M. Mayr,et al. "Going long": long non-coding RNAs as biomarkers. , 2014, Circulation research.
[119] Christina Backes,et al. Influence of the confounding factors age and sex on microRNA profiles from peripheral blood. , 2014, Clinical chemistry.
[120] L. Pennacchio,et al. Functional importance of cardiac enhancer-associated noncoding RNAs in heart development and disease , 2014, Journal of molecular and cellular cardiology.
[121] S. Blankenberg,et al. Assessment of microRNAs in patients with unstable angina pectoris. , 2014, European heart journal.
[122] L. Goedeke,et al. microRNAs and HDL life cycle. , 2014, Cardiovascular research.
[123] T. Tuschl,et al. Comparative RNA-sequencing analysis of myocardial and circulating small RNAs in human heart failure and their utility as biomarkers , 2014, Proceedings of the National Academy of Sciences.
[124] E. van Rooij,et al. Inhibition of miR-92a improves re-endothelialization and prevents neointima formation following vascular injury , 2014, Cardiovascular research.
[125] Thomas Thum,et al. Circulating microRNAs for predicting and monitoring response to mechanical circulatory support from a left ventricular assist device , 2014, European journal of heart failure.
[126] R. Eritja,et al. Oligonucleotide delivery: a patent review (2010 – 2013) , 2014, Expert opinion on therapeutic patents.
[127] George A. Calin,et al. RNAi Therapies: Drugging the Undruggable , 2014, Science Translational Medicine.
[128] T. Thum,et al. The smooth long noncoding RNA SENCR. , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[129] D. Zheng,et al. Identification and Initial Functional Characterization of a Human Vascular Cell–Enriched Long Noncoding RNA , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[130] Shiyou Zhu,et al. High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells , 2014, Nature.
[131] F. He,et al. Predictive value of circulating miR-328 and miR-134 for acute myocardial infarction , 2014, Molecular and Cellular Biochemistry.
[132] G. Lemesle,et al. Circulating Long Noncoding RNA, LIPCAR, Predicts Survival in Patients With Heart Failure , 2014, Circulation research.
[133] S. Dimmeler,et al. Long Noncoding RNA MALAT1 Regulates Endothelial Cell Function and Vessel Growth , 2014, Circulation Research.
[134] D. G. MacArthur,et al. Guidelines for investigating causality of sequence variants in human disease , 2014, Nature.
[135] M. Fu,et al. MicroRNA-155 Deficiency Results in Decreased Macrophage Inflammation and Attenuated Atherogenesis in Apolipoprotein E–Deficient Mice , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[136] F. Kiessling,et al. MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1 , 2014, Nature Medicine.
[137] G. Lemesle,et al. The Circulating Long Non-Coding RNA LIPCAR Predicts Survival in Heart Failure Patients , 2014 .
[138] Xiaoying Jiang,et al. Expression profiling of long noncoding RNAs and the dynamic changes of lncRNA-NR024118 and Cdkn1c in angiotensin II-treated cardiac fibroblasts. , 2014, International journal of clinical and experimental pathology.
[139] P. Doevendans,et al. Inhibition of miR-25 Improves Cardiac Contractility in the Failing Heart , 2014, Nature.
[140] Jincheng Li,et al. Mitofusin 1 Is Negatively Regulated by MicroRNA 140 in Cardiomyocyte Apoptosis , 2014, Molecular and Cellular Biology.
[141] G. Ewald,et al. Deep RNA Sequencing Reveals Dynamic Regulation of Myocardial Noncoding RNAs in Failing Human Heart and Remodeling With Mechanical Circulatory Support , 2014, Circulation.
[142] X. Xiao,et al. Decoding the noncoding transcripts in human heart failure. , 2014, Circulation.
[143] L. Aravind,et al. New perspectives on the diversification of the RNA interference system: insights from comparative genomics and small RNA sequencing , 2014, Wiley interdisciplinary reviews. RNA.
[144] S. Boulkroun,et al. Inhibition of MicroRNA-92a Prevents Endothelial Dysfunction and Atherosclerosis in Mice , 2014, Circulation research.
[145] Frank Grützner,et al. The evolution of lncRNA repertoires and expression patterns in tetrapods , 2014, Nature.
[146] J. Burnett,et al. Running interference to lower cholesterol , 2014, The Lancet.
[147] B. Bettencourt,et al. Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial , 2014, The Lancet.
[148] Daniel G. Anderson,et al. In vivo silencing of the transcription factor IRF5 reprograms the macrophage phenotype and improves infarct healing. , 2013, Journal of the American College of Cardiology.
[149] K. Croce,et al. Systemic Delivery of MicroRNA-181b Inhibits Nuclear Factor-&kgr;B Activation, Vascular Inflammation, and Atherosclerosis in Apolipoprotein E–Deficient Mice , 2013, Circulation research.
[150] K. Morgan,et al. Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes , 2013, European heart journal.
[151] Xiaomin Wang,et al. Single-target RNA interference for the blockade of multiple interacting proinflammatory and profibrotic pathways in cardiac fibroblasts. , 2014, Journal of molecular and cellular cardiology.
[152] A. Lusis,et al. Systems genetics approaches to understand complex traits , 2013, Nature Reviews Genetics.
[153] E. Cuppen,et al. Extensive localization of long noncoding RNAs to the cytosol and mono- and polyribosomal complexes , 2014, Genome Biology.
[154] H. Jo,et al. The atypical mechanosensitive microRNA-712 derived from pre-ribosomal RNA induces endothelial inflammation and atherosclerosis , 2013, Nature Communications.
[155] K. Rapti,et al. SUMO-1 Gene Transfer Improves Cardiac Function in a Large-Animal Model of Heart Failure , 2013, Science Translational Medicine.
[156] R. Liao,et al. MicroRNA-26a Regulates Pathological and Physiological Angiogenesis by Targeting BMP/SMAD1 Signaling , 2013, Circulation research.
[157] Daniel Anderson,et al. Delivery materials for siRNA therapeutics. , 2013, Nature materials.
[158] W. Paulus,et al. Myocardial Titin Hypophosphorylation Importantly Contributes to Heart Failure With Preserved Ejection Fraction in a Rat Metabolic Risk Model , 2013, Circulation: Heart Failure.
[159] E. van Rooij,et al. Inhibition of MicroRNA-92a Protects Against Ischemia/Reperfusion Injury in a Large-Animal Model , 2013, Circulation.
[160] B. Bettencourt,et al. Safety and efficacy of RNAi therapy for transthyretin amyloidosis. , 2013, The New England journal of medicine.
[161] C. Skurk,et al. Cardiovascular RNA interference therapy: the broadening tool and target spectrum. , 2013, Circulation research.
[162] Qisheng Peng,et al. Lentivirus-mediated RNA interference of chymase increases the plaque stability in atherosclerosis in vivo. , 2013, Experimental and molecular pathology.
[163] Teri A. Manolio,et al. Bringing genome-wide association findings into clinical use , 2013, Nature Reviews Genetics.
[164] R. Testa,et al. Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. , 2013, International journal of cardiology.
[165] D. Bartel,et al. lincRNAs: Genomics, Evolution, and Mechanisms , 2013, Cell.
[166] S. Fichtlscherer,et al. Heparin selectively affects the quantification of microRNAs in human blood samples. , 2013, Clinical chemistry.
[167] C. Emanueli,et al. Local Inhibition of MicroRNA-24 Improves Reparative Angiogenesis and Left Ventricle Remodeling and Function in Mice With Myocardial Infarction , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[168] Weifeng Wu,et al. MicroRNA-21 and -146b are involved in the pathogenesis of murine viral myocarditis by regulating TH-17 differentiation , 2013, Archives of Virology.
[169] A. Schober,et al. The microRNA-342-5p Fosters Inflammatory Macrophage Activation Through an Akt1- and microRNA-155–Dependent Pathway During Atherosclerosis , 2013, Circulation.
[170] A. Zeiher,et al. Immunosenescence‐associated microRNAs in age and heart failure , 2013, European journal of heart failure.
[171] Daniel G. Anderson,et al. Monocyte-Directed RNAi Targeting CCR2 Improves Infarct Healing in Atherosclerosis-Prone Mice , 2013, Circulation.
[172] Howard Y. Chang,et al. Long Noncoding RNAs: Cellular Address Codes in Development and Disease , 2013, Cell.
[173] H. Hermeking,et al. MicroRNA-34a regulates cardiac ageing and function , 2013, Nature.
[174] M. Mayr,et al. MicroRNAs Within the Continuum of Postgenomics Biomarker Discovery , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[175] R. Pepperkok,et al. RNAi–Based Functional Profiling of Loci from Blood Lipid Genome-Wide Association Studies Identifies Genes with Cholesterol-Regulatory Function , 2013, PLoS genetics.
[176] R. Bak,et al. Potent microRNA suppression by RNA Pol II-transcribed 'Tough Decoy' inhibitors. , 2013, RNA.
[177] Karen S. Frese,et al. Refining diagnostic microRNA signatures by whole-miRNome kinetic analysis in acute myocardial infarction. , 2013, Clinical chemistry.
[178] Vincent L. Butty,et al. Braveheart, a Long Noncoding RNA Required for Cardiovascular Lineage Commitment , 2013, Cell.
[179] R. Bak,et al. Suppression of microRNAs by dual-targeting and clustered Tough Decoy inhibitors , 2013, RNA biology.
[180] M. Taupitz,et al. Rapid binding of electrostatically stabilized iron oxide nanoparticles to THP-1 monocytic cells via interaction with glycosaminoglycans , 2013, Basic Research in Cardiology.
[181] William Stafford Noble,et al. Integrative annotation of chromatin elements from ENCODE data , 2012, Nucleic acids research.
[182] M. Rudin,et al. Loss of AngiomiR-126 and 130a in Angiogenic Early Outgrowth Cells From Patients With Chronic Heart Failure: Role for Impaired In Vivo Neovascularization and Cardiac Repair Capacity , 2012, Circulation.
[183] F. Kiessling,et al. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. , 2012, The Journal of clinical investigation.
[184] S. Kauppinen,et al. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function , 2012, Proceedings of the National Academy of Sciences.
[185] T. Ichim,et al. Induction of Alloimmune Tolerance in Heart Transplantation Through Gene Silencing of TLR Adaptors , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[186] Xiaobin Luo,et al. Role for MicroRNA-21 in Atrial Profibrillatory Fibrotic Remodeling Associated With Experimental Postinfarction Heart Failure , 2012, Circulation. Arrhythmia and electrophysiology.
[187] M. Al-Omran,et al. MicroRNA-145 Targeted Therapy Reduces Atherosclerosis , 2012, Circulation.
[188] Data production leads,et al. An integrated encyclopedia of DNA elements in the human genome , 2012 .
[189] S. Dimmeler,et al. Atheroprotective mechanisms of shear stress-regulated microRNAs , 2012, Thrombosis and Haemostasis.
[190] Ross C. Hardison,et al. Genome-wide Epigenetic Data Facilitate Understanding of Disease Susceptibility Association Studies* , 2012, The Journal of Biological Chemistry.
[191] David G. Knowles,et al. The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression , 2012, Genome research.
[192] Raymond K. Auerbach,et al. An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.
[193] Bronwen L. Aken,et al. GENCODE: The reference human genome annotation for The ENCODE Project , 2012, Genome research.
[194] Yanjie Lu,et al. MicroRNA-101 Inhibited Postinfarct Cardiac Fibrosis and Improved Left Ventricular Compliance via the FBJ Osteosarcoma Oncogene/Transforming Growth Factor-&bgr;1 Pathway , 2012, Circulation.
[195] Stephane Heymans,et al. MicroRNA Profiling Identifies MicroRNA-155 as an Adverse Mediator of Cardiac Injury and Dysfunction During Acute Viral Myocarditis , 2012, Circulation research.
[196] M. Mayr,et al. Prospective study on circulating MicroRNAs and risk of myocardial infarction. , 2012, Journal of the American College of Cardiology.
[197] Steven P Schwendeman,et al. Vascular Endothelial Cell-specific MicroRNA-15a Inhibits Angiogenesis in Hindlimb Ischemia*♦ , 2012, The Journal of Biological Chemistry.
[198] Howard Y. Chang,et al. Genome regulation by long noncoding RNAs. , 2012, Annual review of biochemistry.
[199] M. McCrae,et al. Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex‐determining region Y box 6 in hepatocellular carcinoma , 2012, Cancer.
[200] J. Mattick,et al. Genome-wide analysis of long noncoding RNA stability , 2012, Genome research.
[201] T. Boettger,et al. A New Level of Complexity: The Role of MicroRNAs in Cardiovascular Development , 2012, Circulation research.
[202] Achilleas S. Frangakis,et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs , 2012, Nature Cell Biology.
[203] M. Abdellatif. Differential Expression of MicroRNAs in Different Disease States , 2012, Circulation research.
[204] E. van Rooij,et al. Developing microRNA therapeutics. , 2012, Circulation research.
[205] Manuel Mayr,et al. MicroRNAs in vascular and metabolic disease. , 2012, Circulation research.
[206] M. Lindholm,et al. PCSK9 LNA antisense oligonucleotides induce sustained reduction of LDL cholesterol in nonhuman primates. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[207] T. Katsuya,et al. Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B. , 2012, Atherosclerosis.
[208] Tetsuo Yoshida,et al. A potent 2′-O-methylated RNA-based microRNA inhibitor with unique secondary structures , 2012, Nucleic acids research.
[209] E. Olson,et al. Inhibition of miR-15 Protects Against Cardiac Ischemic Injury , 2012, Circulation research.
[210] R. Gambari,et al. Targeting microRNAs involved in human diseases: a novel approach for modification of gene expression and drug development. , 2011, Biochemical pharmacology.
[211] J. Bauersachs,et al. Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. , 2011, Journal of molecular and cellular cardiology.
[212] S. Fichtlscherer,et al. Transcoronary Concentration Gradients of Circulating MicroRNAs , 2011, Circulation.
[213] M. Torrado,et al. Targeted Gene-Silencing Reveals the Functional Significance of Myocardin Signaling in the Failing Heart , 2011, PloS one.
[214] Robert M. Goor,et al. Assessing and managing risk when sharing aggregate genetic variant data , 2011, Nature Reviews Genetics.
[215] Daniel G. Anderson,et al. Therapeutic siRNA silencing in inflammatory monocytes , 2011, Nature Biotechnology.
[216] E. Kizana,et al. SUMO1-dependent modulation of SERCA2a in heart failure , 2011, Nature.
[217] T. Tuschl,et al. MicroRNA-24 Regulates Vascularity After Myocardial Infarction , 2011, Circulation.
[218] Hsien-Da Huang,et al. Flow-Dependent Regulation of Kruppel-Like Factor 2 Is Mediated by MicroRNA-92a. , 2011, Circulation.
[219] Barry Greenberg,et al. Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): A Phase 2 Trial of Intracoronary Gene Therapy of Sarcoplasmic Reticulum Ca2+-ATPase in Patients With Advanced Heart Failure , 2011, Circulation.
[220] Gang Bao,et al. MicroRNA Expression Profile in CAD Patients and the Impact of ACEI/ARB , 2011, Cardiology research and practice.
[221] D. Erlinge,et al. Cardiospecific microRNA Plasma Levels Correlate with Troponin and Cardiac Function in Patients with ST Elevation Myocardial Infarction, Are Selectively Dependent on Renal Elimination, and Can Be Detected in Urine Samples , 2011, Cardiology.
[222] L. V. Van Laake,et al. miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes , 2011, The Journal of experimental medicine.
[223] I. Bièche,et al. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[224] H. Fechner,et al. microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors , 2011, Gene Therapy.
[225] E. Rooij,et al. The Art of MicroRNA Research , 2011 .
[226] S. Steinhubl,et al. New Drugs and Technologies , 2014 .
[227] W. Zimmermann,et al. Common MicroRNA Signatures in Cardiac Hypertrophic and Atrophic Remodeling Induced by Changes in Hemodynamic Load , 2010, PloS one.
[228] Jan A Staessen,et al. Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease , 2010, Circulation. Cardiovascular genetics.
[229] Fabio Martelli,et al. MicroRNA-210 as a Novel Therapy for Treatment of Ischemic Heart Disease , 2010, Circulation.
[230] John J Rossi,et al. Biogenesis and function of endogenous and exogenous siRNAs , 2010, Wiley interdisciplinary reviews. RNA.
[231] Federica Limana,et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction , 2010, European Heart Journal.
[232] M. Toloue,et al. Delivery of RNAi mediators , 2010, Wiley interdisciplinary reviews. RNA.
[233] T. V. van Berkel,et al. The peripheral blood mononuclear cell microRNA signature of coronary artery disease. , 2010, Biochemical and biophysical research communications.
[234] Yue Li,et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. , 2010, European heart journal.
[235] J. Mattick,et al. A global view of genomic information--moving beyond the gene and the master regulator. , 2010, Trends in genetics : TIG.
[236] Hugo A. Katus,et al. MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction , 2010, Basic Research in Cardiology.
[237] M. Hristov,et al. Delivery of MicroRNA-126 by Apoptotic Bodies Induces CXCL12-Dependent Vascular Protection , 2009, Science Signaling.
[238] Xiaomin Wang,et al. Prevention of Cardiac Dysfunction in Acute Coxsackievirus B3 Cardiomyopathy by Inducible Expression of a Soluble Coxsackievirus-Adenovirus Receptor , 2009, Circulation.
[239] Sudhiranjan Gupta,et al. Silencing the myotrophin gene by RNA interference leads to the regression of cardiac hypertrophy. , 2009, American journal of physiology. Heart and circulatory physiology.
[240] Stefanie Dimmeler,et al. MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice , 2009, Science.
[241] P. O’Reilly,et al. Genome-wide association study identifies eight loci associated with blood pressure , 2009, Nature Genetics.
[242] G. Boysen,et al. European Guidelines on Cardiovascular Disease Prevention , 2009, International journal of stroke : official journal of the International Stroke Society.
[243] Da-Zhi Wang,et al. A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection , 2009, Proceedings of the National Academy of Sciences.
[244] Derek J Van Booven,et al. Reciprocal Regulation of Myocardial microRNAs and Messenger RNA in Human Cardiomyopathy and Reversal of the microRNA Signature by Biomechanical Support , 2009, Circulation.
[245] V. Erdmann,et al. Long-Term Cardiac-Targeted RNA Interference for the Treatment of Heart Failure Restores Cardiac Function and Reduces Pathological Hypertrophy , 2009, Circulation.
[246] H. Iba,et al. Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells , 2009, Nucleic acids research.
[247] W. Rottbauer,et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts , 2008, Nature.
[248] David L. Spector,et al. 3′ End Processing of a Long Nuclear-Retained Noncoding RNA Yields a tRNA-like Cytoplasmic RNA , 2008, Cell.
[249] H. Sweeney,et al. Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat. , 2008, Human gene therapy.
[250] X. Chen,et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.
[251] Robert Langer,et al. Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates , 2008, Proceedings of the National Academy of Sciences.
[252] Danish Sayed,et al. MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. , 2008, Molecular biology of the cell.
[253] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[254] Margaret S. Ebert,et al. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells , 2007, Nature Methods.
[255] C. Croce,et al. MicroRNA-133 controls cardiac hypertrophy , 2007, Nature Medicine.
[256] Xiaoxia Qi,et al. Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA , 2007, Science.
[257] Thomas Thum,et al. MicroRNAs in the Human Heart: A Clue to Fetal Gene Reprogramming in Heart Failure , 2007, Circulation.
[258] P. Zamore. RNA Interference: Big Applause for Silencing in Stockholm , 2006, Cell.
[259] T. Conlon,et al. Recombinant Adeno-Associated Virus Serotype 9 Leads to Preferential Cardiac Transduction In Vivo , 2006, Circulation research.
[260] Theresa A. Storm,et al. Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[261] James M. Wilson,et al. High-Level Transgene Expression in Nonhuman Primate Liver with Novel Adeno-Associated Virus Serotypes Containing Self-Complementary Genomes , 2006, Journal of Virology.
[262] Theresa A. Storm,et al. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways , 2006, Nature.
[263] N. Rajewsky,et al. Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.
[264] V. Erdmann,et al. Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2'-O-methyl RNA, phosphorothioates and small interfering RNA. , 2003, Nucleic acids research.
[265] Lili Wang,et al. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[266] T. Tuschl,et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.
[267] A. Fire,et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.